High Working Capital Days
Receivable days are currently ~290 days, posing cash flow risk. Management targets reduction to 150-160 days by FY27, but execution is uncertain.
ANLONHEALTHCARE / Q3-FY26 / risks
Keep the risk register visible.
Anlon Healthcare · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Integration and Execution Risk from Acquisitions
Acquisitions of Epico and Bizotic require smooth integration; any delays or operational issues could impact revenue and margin targets.
Customer Concentration in NSAID Segment
~30-35% revenue from loxoprofen and ketoprofen; any demand shock or regulatory issue in this segment could materially affect results.
Capacity Constraints Before Greenfield Completion
Existing facilities are near full utilization; until greenfield expansion is operational (by March 2027), growth may be constrained.